![Upregulation of heat shock protein 27 confers resistance to actinomycin D‐induced apoptosis in cancer cells - Ma - 2013 - The FEBS Journal - Wiley Online Library Upregulation of heat shock protein 27 confers resistance to actinomycin D‐induced apoptosis in cancer cells - Ma - 2013 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/c04ccd96-3604-4076-8954-3655eab83342/febs12432-fig-0003-m.jpg)
Upregulation of heat shock protein 27 confers resistance to actinomycin D‐induced apoptosis in cancer cells - Ma - 2013 - The FEBS Journal - Wiley Online Library
![Multidimensional role of bacteria in cancer: Mechanisms insight, diagnostic, preventive and therapeutic potential - ScienceDirect Multidimensional role of bacteria in cancer: Mechanisms insight, diagnostic, preventive and therapeutic potential - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1044579X21001814-ga1.jpg)
Multidimensional role of bacteria in cancer: Mechanisms insight, diagnostic, preventive and therapeutic potential - ScienceDirect
![Amazon.com: Light Therapy Lamp, UV-Free 10000 Lux Therapy Light Daylight Lamp Touch Control with 3 Adjustable Brightness Levels & 4 Timer Function, Large Light Surface & Rotatable Stand for Home/Office : Health Amazon.com: Light Therapy Lamp, UV-Free 10000 Lux Therapy Light Daylight Lamp Touch Control with 3 Adjustable Brightness Levels & 4 Timer Function, Large Light Surface & Rotatable Stand for Home/Office : Health](https://m.media-amazon.com/images/I/51xtoyr-ohL._AC_UF1000,1000_QL80_.jpg)
Amazon.com: Light Therapy Lamp, UV-Free 10000 Lux Therapy Light Daylight Lamp Touch Control with 3 Adjustable Brightness Levels & 4 Timer Function, Large Light Surface & Rotatable Stand for Home/Office : Health
![Functional FCGR3A 158 V/F and IL-6 −174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis | SpringerLink Functional FCGR3A 158 V/F and IL-6 −174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00296-014-3015-1/MediaObjects/296_2014_3015_Fig2_HTML.gif)
Functional FCGR3A 158 V/F and IL-6 −174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis | SpringerLink
![Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging | Molecular Pharmaceutics Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.1c00002/asset/images/large/mp1c00002_0002.jpeg)
Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging | Molecular Pharmaceutics
Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging | Molecular Pharmaceutics
![Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging | Molecular Pharmaceutics Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.1c00002/asset/images/large/mp1c00002_0001.jpeg)
Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging | Molecular Pharmaceutics
![Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls | Immunotherapy Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls | Immunotherapy](https://www.futuremedicine.com/cms/10.2217/imt.10.67/asset/images/medium/figure1.gif)
Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls | Immunotherapy
![Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial | Annals of the Rheumatic Diseases Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial | Annals of the Rheumatic Diseases](https://ard.bmj.com/sites/default/files/highwire/annrheumdis/82/8.cover-source.jpg)
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial | Annals of the Rheumatic Diseases
![Frontiers | Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases Frontiers | Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases](https://www.frontiersin.org/files/Articles/712645/fmed-08-712645-HTML/image_m/fmed-08-712645-g001.jpg)
Frontiers | Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases
![Upregulation of heat shock protein 27 confers resistance to actinomycin D‐induced apoptosis in cancer cells - Ma - 2013 - The FEBS Journal - Wiley Online Library Upregulation of heat shock protein 27 confers resistance to actinomycin D‐induced apoptosis in cancer cells - Ma - 2013 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/62de2143-8a39-4bb3-964d-f9f713436020/febs12432-toc-0001-m.jpg?trick=1687847358239)